Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 29,27
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Cambridge University Press 10/2/2000, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: BargainBookStores, Grand Rapids, MI, U.S.A.
Paperback or Softback. Condizione: New. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990. Book.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: California Books, Miami, FL, U.S.A.
EUR 32,04
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 30,59
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: Paisleyhaze Books, New Hartford, CT, U.S.A.
Prima edizione
Soft cover. Condizione: New. 1st Edition. Cambridge University Press trade paperback, unused and carefully stored, No marks/creases or other defects; (as New). We will bubble wrap the book and ship it in a New BOX- Not a plastic bag like the zombie sellers.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: GoldBooks, Denver, CO, U.S.A.
Paperback. Condizione: new. New Copy. Customer Service Guaranteed.
Lingua: Inglese
Editore: Cambridge University Press 2009-03-09, 2009
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: Chiron Media, Wallingford, Regno Unito
EUR 28,29
Quantità: Più di 20 disponibili
Aggiungi al carrelloPaperback. Condizione: New.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 31,25
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Cambridge University Press, 2000., 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Condizione: near fine. pbk 258pp excellent almost as new.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 35,05
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 44,75
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: Cambridge University Press, 2009
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Prima edizione
EUR 51,00
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Explores the origins of contemporary drug regulation and the modern clinical trial. Series Editor(s): Rosenberg, Charles; Jones, Colin A. Series: Cambridge Studies in the History of Medicine. Num Pages: 272 pages, black & white illustrations. BIC Classification: MBX. Category: (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 152 x 230 x 21. Weight in Grams: 426. . 2009. 1st Edition. paperback. . . . .
Lingua: Inglese
Editore: Cambridge University Press CUP, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 272.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: Kennys Bookstore, Olney, MD, U.S.A.
EUR 63,38
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Explores the origins of contemporary drug regulation and the modern clinical trial. Series Editor(s): Rosenberg, Charles; Jones, Colin A. Series: Cambridge Studies in the History of Medicine. Num Pages: 272 pages, black & white illustrations. BIC Classification: MBX. Category: (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 152 x 230 x 21. Weight in Grams: 426. . 2009. 1st Edition. paperback. . . . . Books ship from the US and Ireland.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: BennettBooksLtd, Los Angeles, CA, U.S.A.
paperback. Condizione: New. In shrink wrap. Looks like an interesting title!
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 45,28
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - How do we evaluate the safety and benefit of new drugs What tasks do we hold the government responsible for and which ones do we leave to the medical profession Harry Marks explores the origins of our contemporary system of drug regulation and the modern clinical trial. He shows that the story of modern drug regulation is synonymous with the history of therapeutic reform. Accompanying this history of public policy is a detailed account of changing experimental ideal and practices. Marks follows the history of therapeutic experimentation, from the 'collective investigations' of the last century to the controlled clinical trial which emerged after 1950 as the paradigm of scientific experimentation. The result is the first general history of clinical research in the United States, a book which examines therapeutic experiments in a wide range of diseases, from syphilis and pneumonia to heart disease and diabetes.
Lingua: Inglese
Editore: Cambridge University Press, Cambridge, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Prima edizione Print on Demand
Paperback. Condizione: new. Paperback. This book explores the origins of our contemporary system of drug regulation and the modern clinical trial. Marks illustrates the symbiotic relationship between the history of modern drug regulation and the history of therapeutic reform. Accompanying this history of public policy is a detailed account of changing experimental ideals and practices. Marks traces the history of therapeutic experimentation, from the "collective investigations" of the past century to the controlled clinical trial that emerged after 1950 as the paradigm of scientific experimentation. The result is the first general history of clinical research in the United States, a book that examines therapeutic experiments in a wide range of diseases, from syphilis and pneumonia to heart disease and diabetes. This book explores the origins of our contemporary system of drug regulation and of the modern clinical trial. Harry Marks looks at the science and politics of drug evaluation and explores the influence of academic ideals on governmental drug regulation. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Da: Revaluation Books, Exeter, Regno Unito
EUR 26,37
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 1st edition. 271 pages. 8.75x6.00x0.75 inches. In Stock. This item is printed on demand.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 32,15
Quantità: Più di 20 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: Majestic Books, Hounslow, Regno Unito
EUR 61,91
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 272 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.
Lingua: Inglese
Editore: Cambridge University Press, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 61,67
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 272.
Lingua: Inglese
Editore: Cambridge University Press, Cambridge, 2000
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: CitiRetail, Stevenage, Regno Unito
Prima edizione Print on Demand
EUR 36,98
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: new. Paperback. This book explores the origins of our contemporary system of drug regulation and the modern clinical trial. Marks illustrates the symbiotic relationship between the history of modern drug regulation and the history of therapeutic reform. Accompanying this history of public policy is a detailed account of changing experimental ideals and practices. Marks traces the history of therapeutic experimentation, from the "collective investigations" of the past century to the controlled clinical trial that emerged after 1950 as the paradigm of scientific experimentation. The result is the first general history of clinical research in the United States, a book that examines therapeutic experiments in a wide range of diseases, from syphilis and pneumonia to heart disease and diabetes. This book explores the origins of our contemporary system of drug regulation and of the modern clinical trial. Harry Marks looks at the science and politics of drug evaluation and explores the influence of academic ideals on governmental drug regulation. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Lingua: Inglese
Editore: Cambridge University Press, 2008
ISBN 10: 0521785618 ISBN 13: 9780521785617
Da: moluna, Greven, Germania
EUR 37,79
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This book explores the origins of our contemporary system of drug regulation and of the modern clinical trial. Harry Marks looks at the science and politics of drug evaluation and explores the influence of academic ideals on governmental drug regulation.